bg
I

Immunome (IMNM)

$000.00 0.00% ($0.00)

  • Today
  • Week
  • Month
  • Year
  • 5 Year
  • YTD
barakagetbaraka.com

About Immunome (IMNM)

Immunome, Inc. is a biotechnology company engaged in developing targeted cancer therapies. The Company’s portfolio pursues each target with a modality appropriate to its biology, including immunotherapies, targeted effectors, radioligand therapies an... Read more

  • USD9.74
  • USD10.03
  • USD9.60
  • USD16.73
  • 13.30%
  • 11M
  • 580.88k
  • 1.02M
  • 921M
  • 5.15
  • -25.10%

Unlock More Stock Analysis & Reports

Access detailed stock analysis from LSEG including analyst price target estimates.